Aurobindo gets USFDA approval for Dapagliflozin with 180-day exclusivity
Immediate U.S. launch planned for Farxiga®-equivalent diabetes drug; opportunity pegged at $10.2 billion in annual market size
Immediate U.S. launch planned for Farxiga®-equivalent diabetes drug; opportunity pegged at $10.2 billion in annual market size
Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
Safety was equally impressive. ENV-294 was well tolerated
He brings extensive cross-functional expertise built through leadership roles
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Subscribe To Our Newsletter & Stay Updated